New development at the University of Sheffield will double the research capacity of the world-leading research facility, accelerating the progress of breakthrough treatments for degenerative neurological diseases such as Alzheimer’s, Multiple Sclerosis (MS), Parkinson’s and Motor Neuron Disease (MND)